Source: El Pais, supplement "Health", 5.11.2002; message from elektrosmognews

Mortality in leukaemia in Spain in the last 10 years climbed annually around 1,7 (men) and/or 1,4 percent (women).

The Spanish epidemiologist Rafael Gabriel Sánchez, who conducted a statistical leukaemia study of the Spanish Foundation Leukaemia and Lymphoma (published in the "White Paper of the Leukaemia in Spanien 2002") Leukaemia, counts electro magnetic fields to the head-environment risk factors for leukaemia.

The study emerged under cooperation of the Spanish Association for Haematology and Haemotherapy, the Spanish Transplant-Organization and the Health- and Consumer ministry. The examined population represents 20 millions of Spaniards.

After the study the amount concerning to the 5-year-actuarial survival rate with leukaemia in Spain at presents is about 40%, i.e. 60% of the diseased live after 5 years no longer. In Denmark, even 71% of the diseased in the period of 5 years die after outbreak of the illness, in France 51%. The actuarial survival rate shows large differences depending upon the type of the leukaemia.

After the results of the study, which was coordinated by the epidemiologist Rafael Gabriel Sánchez, the mortality climbed in leukaemia in the last ten years annually around 1,7% with men and 1,4% with women. After the words of Sanchez, many risk factors exist for leukaemia as well as genetic components. In the largest number of the cases of acute leukaemia, chromosomes variations were found, without that the responsible environment factors were found. Nevertheless, so Sanchez, we count the following environment influences now as ever to the head-environment risk factors: ionising radiation, different solvents and plant protectants, determined treatment form in chemotherapy, electro magnetic fields and viruses.

BBC NEWS
Phone mast is vandalised

Sunday, 19 January, 2003, 18:17 GMT

It is the second such attack in County Tyrone

A mobile phone mast has been cut down in County Tyrone. It happened on the Ballyrea Road in Ballygawley on Saturday night. More than £20,000 worth of damage was caused. The mast belongs to a mobile phone company.

Anthony McGonnell: "Genuine concerns in the community" Last month, vandals destroyed an NIE mast at nearby Cran Lome. Local people said they believed the masts pose a health risk and in recent weeks, hundreds of people have attended public meetings in the area.

'Suspicious activity'

The identity of those behind the latest attack is unknown, but local SDLP councillor Anthony McGonnell said there were genuine concerns in the community. "While I would not condone people taking the law into their own hands... the reason why these acts are taking place is because people are panicking," he said.

The police want to hear from anyone who noticed suspicious activity in the Ballyrea Road before the damage was reported at about 2230 GMT on Saturday.

The previous attack involved a mast which forms part of Northern Ireland Electricity's (NIE) communication system. It is also used by several mobile telephone companies.

A spokeswoman for the company said the vandals had put themselves at risk and left the company's communication system vulnerable.

Local residents said the erection of the mast was responsible for cancer-related illnesses in the area.

Many communities across Northern Ireland have campaigned against phone masts over fears that low level radiation could pose a health risk to people living near the ariels.

http://news.bbc.co.uk/2/hi/uk_news/northern_ireland/2674727.stm

Informant: Robert Riedlinger

FDA recall of PHENYLPROPANOLAMINE

All drugs containing PHENYLPROPANOLAMINE are being recalled. You may want to try calling the 800 number listed on most drug boxes and inquire about a REFUND. Please read this CAREFULLY. Also, please pass this on to everyone you know.

STOP TAKING anything containing this ingredient. It has been linked to increased hemorrhagic stroke (bleeding in brain) among women ages 18-49 in the three days after starting use of medication. Problems were not found in men, but the FDA recommended that everyone (even children) seek alternative medicine.

The following medications contain Phenylpropanolamine:

Acutrim Diet Gum Appetite Suppressant
Acutrim Plus Dietary Supplements
Acutrim Maximum Strength Appetite Control
Alka-Seltzer Plus Children's Cold Medicine Effervescent
Alka-Seltzer Plus Cold medicine (cherry or orange)
Alka-Seltzer Plus Cold Medicine Original
Alka-Seltzer Plus Cold &Cough Medicine Effervescent
Alka-Seltzer Plus Cold &Flu Medicine
Alka-Seltzer Plus Cold &Sinus Effervescent
Alka Seltzer Plus Night-Time Cold Medicine
BC Allergy Sinus Cold Powder
BC Sinus Cold Powder
Comtrex Flu Therapy &Fever Relief

Contac 12 Hour Caplets
Coricidin D Cold, Flu &Sinus
Day &Night Contac 12-Hour Cold Capsules
Dexatrim Caffeine Free
Dexatrim Extended Duration
Dexatrim Gelcaps
Dexatrim Vitamin C/Caffeine Free
Dimetapp Cold &Allergy Chewable Tablets
Dimetapp Cold &Cough Liqui-Gels
Dimetapp DM Cold &Cough Elixir
Dimetapp Elixir
Dimetapp 4 Hour Liquid Gels
Dimetapp 4 Hour Tablets
Dimetapp 12 Hour Extentabs Tablets
Naldecon DX Pediatric Drops
Permathene Mega-16
Robitussin CF
Tavist-D 12 Hour Relief of Sinus &Nasal

Congestion
Triaminic DM Cough Relief
Triaminic Expectorant Chest &Head
Triaminic Syrup Cold &Allergy
Triaminic Triaminicol Cold &Cough ....

I just found out and called the 800# on the container for Triaminic and they informed me that they are voluntarily recalling the following medicines because of a certain ingredient that is causing strokes and seizures in children:

Orange 3D Cold &Allergy Cherry (Pink)
3D Cold &Cough Berry
3D Cough Relief Yellow 3D Expectorant

They are asking you to call them at 800-548-3708 with the lot number on the box so they can send you postage for you to send it back to them, and they will also issue you a refund.

If you know of anyone else with small children, PLEASE PASS THIS ON. THIS IS SERIOUS STUFF!

DO PASS ALONG TO ALL ON YOUR MAILING LIST so people are informed. They can then pass it along to their families.

To confirm these findings please take time to check the following:

URL: Phenylpropanolamine Information Page http://www.fda.gov/cder/drug/infopage/ppa/default.htm

The Food and Drug Administration (FDA) is taking steps to remove phenylpropanolamine (PPA) from all drug products and has requested that all drug companies discontinue marketing products containing PPA. In addition, FDA has issued a public health advisory concerning phenylpropanolamine. This drug is an ingredient used in many over-the-counter (OTC) and prescription cough and cold medications as a decongestant and in OTC weight loss products.

We have received numerous requests for a list of products containing PPA. In response to the request made by FDA in November 2000, many companies have voluntarily reformulated and are continuing to reformulate their products to exclude PPA while FDA proceeds with the regulatory process necessary to remove PPA from the market. Therefore, there is no comprehensive, updated list available from FDA. FDA is aware of emails circulating widely that list many products allegedly containing PPA. Those emails are no longer valid and should be ignored. Please read the labels of OTC products to determine if they contain PPA. (Paragraph added 2/20/2002)

Scientists at Yale University School of Medicine recently issued a report entitled "Phenylpropanolamine & Risk of Hemorrhagic Stroke: Final Report of the Hemorrhagic Stroke Project." This study reports that taking PPA increases the risk of hemorrhagic stroke (bleeding into the brain or into tissue surrounding the brain) in women. Men may also be at risk. Although the risk of hemorrhagic stroke is very low, FDA recommends that consumers not use any products that contain PPA.

FDA's Nonprescription Drugs Advisory Committee recently discussed this Yale study along with additional information on phenylpropanolamine. The Advisory Committee determined that there is an association between PPA and hemorrhagic stroke. It recommended that PPA be considered not safe for over-the-counter use.

Informant: Colette O'Connell message from Roy Beavers